Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

This grant supports research focused on the clinical development and validation of predictive biomarkers for disease progression and treatment response in chronic non-communicable diseases (excluding cancer) using established AI methodologies. The aim is to combine data from clinically used and candidate biomarkers, along with clinical studies and Real-World Data, to enable timely and effective therapeutic interventions. The expected outcomes include the development of novel, clinically validated predictive biomarkers that improve patient outcomes, support personalised medicine, and provide healthcare professionals with trustworthy AI tools for decision support.

AgencyHORIZON (EU)
RegionEU
CountryN/A
Legal formCompany, NGO, Government organization, Other
Start date10 Feb 2027
End date13 Apr 2027
Max funding6,000,000 – 8,000,000 EUR per grant
Budget44,200,000 EUR (2027 call budget for topic HORIZON-HLTH-2027-02-TOOL-01-two-stage)
Coverage

Union funding can be provided to entities established in EU Member States, Associated Countries, and, under certain provisions, the USA. Non-EU/non-Associated Countries may participate under specific conditions. Detailed eligibility and coverage conditions are outlined in the Horizon Europe Work Programme.

Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases • EUGrants.AI